melanotan peptide 2 Skin Results October 2017 | VOL. 14,

Monitoring Schedule Serum IGF-1 at baseline and at 8-12 weeks Fasting glucose at baseline and every 3-6 months (GH increases insulin resistance acutely) Thyroid panel at baseline (hypothyroidism blunts IGF-1 response) Blood pressure and fluid retention assessment at each visit The American Association of Clinical Endocrinology (AACE) recommends IGF-1 be kept within the age- and sex-adjusted reference range during any GH-stimulating therapy to minimize risk of adverse effects including fluid retention and glucose intolerance [9]

Enhanced collagen and ECM remodeling activity

The product is intended for healthy people over 18 years of age

Its ideal for clients looking for quick results with a minimally invasive approach